EUVIMEDEUVIMED entdecken
Crossref

Knockdown of CENPN Inhibits Glucose Metabolism and Induces G1 Arrest in Esophageal Cancer Cells by Regulating PI3K/AKT Signaling Pathway

Shasha Xu, Xing Wei

Hormone and Metabolic Research · 01.08.2023 · 55 (08) · 563-572

DOI: 10.1055/a-2084-3112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.08.2023. Verfasst von Shasha Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hangzhou Ninth People's Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Esophageal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal carcinoma (ESCA) is a deadly malignancy with an increasing incidence year by year. The purpose of this study was to explore the function of CENPN in ESCA. Based on TCGA public data platform, the transcription level of CENPN in ESCA was analyzed. Subsequently, ESCA cells with CENPN overexpression or knockdown were constructed. The proliferation and migration levels of ESCA cells were evaluated by CCK-8, colony formation assay, and transwell analysis. Western blotting was used to detect protein levels associated with CyclinD1, CDK2, GLUT1, and PI3K/AKT signaling pathways. Cell cycle distribution was measured by flow cytometry. Glucose consumption and lactate production in ESCA cells were measured. CENPN was overexpressed in ESCA. In vitro experiments showed that CENPN promoted the proliferation and migration of ESCA cells, and upregulated the levels of CyclinD1, CDK2, and GLUT1, promoting the cell cycle process, increasing glucose consumption and lactic acid production. In addition, CENPN overexpression increased the phosphorylation levels of PI3K and AKT. The results suggest that the abnormal expression of CENPN in ESCA may enhance the malignant phenotype of ESCA cells by activating the PI3K/AKT signaling pathway. CENPN is expected to be a new target for ESCA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktEsophageal NeoplasmsHumansPhosphatidylinositol 3-KinasesGlucose Transporter Type 1Cell ProliferationSignal TransductionCell Line, TumorChromosomal Proteins, Non-Histone

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesGlucose Transporter Type 1CENPN protein, humanChromosomal Proteins, Non-Histone

Autor:innen und Institutionen

  • Department of Gastroenterology, Hangzhou Ninth People's Hospital, Hangzhou, China.
  • Department of Biochemistry and Cell Biology, Youjiang Medical University for Nationalities, Baise, China.

Zitieren

APA

Xu, S., & Wei, X. (2023). Knockdown of CENPN Inhibits Glucose Metabolism and Induces G1 Arrest in Esophageal Cancer Cells by Regulating PI3K/AKT Signaling Pathway. Hormone and Metabolic Research, 55(08), 563-572. https://doi.org/10.1055/a-2084-3112

Vancouver

Xu S, Wei X. Knockdown of CENPN Inhibits Glucose Metabolism and Induces G1 Arrest in Esophageal Cancer Cells by Regulating PI3K/AKT Signaling Pathway. Hormone and Metabolic Research. 2023;55(08):563-572. doi:10.1055/a-2084-3112

BibTeX
@article{Xu2023,
  author = {Xu, Shasha and Wei, Xing},
  title = {Knockdown of CENPN Inhibits Glucose Metabolism and Induces G1 Arrest in Esophageal Cancer Cells by Regulating PI3K/AKT Signaling Pathway},
  journal = {Hormone and Metabolic Research},
  year = {2023},
  volume = {55},
  number = {08},
  pages = {563--572},
  doi = {10.1055/a-2084-3112}
}
Kostenlos starten →